Why is Aarti Pharma falling/rising?

As of 31-Jul, Aarti Pharmalabs Ltd's stock price is currently at 912.20, reflecting a decrease of 26.85 points or 2.86%. The stock has underperformed its sector today by 1.37% and has experienced a trend reversal, falling after two consecutive days of gains. It touched an intraday low of Rs 901.6, which is a decline of 3.99%. In the past week, the stock has decreased by 2.75%, while over the past month, it has remained relatively flat with a change of -0.04%. Despite a strong year-to-date return of 32.73% and a notable 44.61% increase over the past year, the stock's recent performance is tempered by a decline in investor participation, as evidenced by a 34.42% drop in delivery volume compared to the five-day average. Additionally, while the company has a strong ability to service debt and has reported positive financial metrics, concerns about poor long-term growth and reducing promoter confidence may be contributing to the current downward pressure on the stock. In the broader market context, Aarti Pharmalabs Ltd's recent performance contrasts with the benchmark, as the Sensex has only declined by 1.22% over the past week. This indicates that while the stock has been performing well over the longer term, its short-term movements are not aligned with the overall market trend. The stock's ability to generate significant returns despite a negative market backdrop highlights its strong fundamentals; however, the recent decline suggests that investors may be reacting to the potential risks associated with long-term growth and promoter confidence.